未登录

Z

Zdzisław Chilmończyk

uit the arctic university of tromso

H指数:22

被引数:1,569

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

In the triple-negative breast cancer MDA-MB-231 cell line, sulforaphane enhances the intracellular accumulation and anticancer action of doxorubicin encapsulated in liposomes

INTERNATIONAL JOURNAL OF PHARMACEUTICS

IF5.2

2019-03-0144

PREAI

In Vitro Evaluation of Sulforaphane and a Natural Analog as Potent Inducers of 5-Fluorouracil Anticancer Activity

IF4.6

2018-11-2117

OAAI

Autophagic cell death and premature senescence: New mechanism of 5-fluorouracil and sulforaphane synergistic anticancer effect in MDA-MB-231 triple negative breast cancer cell line (vol 111, pg 1, 2018)

FOOD AND CHEMICAL TOXICOLOGY

IF3.5

2018-08-010

PREAI

Deoxynucleosides with benzimidazoles as aglycone moiety are potent anticancer agents

EUROPEAN JOURNAL OF PHARMACOLOGY

IF4.7

2018-02-0113

PREAI

Autophagic cell death and premature senescence: New mechanism of 5-fluorouracil and sulforaphane synergistic anticancer effect in MDA-MB-231 triple negative breast cancer cell line

FOOD AND CHEMICAL TOXICOLOGY

IF3.5

2018-01-0154

PREAI

Serotonin transporter and receptor ligands with antidepressant activity as neuroprotective and proapoptotic agents

PHARMACOLOGICAL REPORTS

IF3.8

2017-06-0123

PREAI

From Homology Models to a Set of Predictive Binding Pockets-a 5-HT1A Receptor Case Study

JOURNAL OF CHEMICAL INFORMATION AND MODELING

IF5.3

2017-01-1822

OAAI

Organofluorine Isoselenocyanate Analogues of Sulforaphane: Synthesis and Anticancer Activity

IF3.4

2016-10-0720

PREAI

Up-regulation of glutathione-related genes, enzyme activities and transport proteins in human cervical cancer cells treated with doxorubicin

BIOMEDICINE & PHARMACOTHERAPY

IF7.5

2016-10-0129

PREAI

Ligand-directed trafficking of receptor stimulus

PHARMACOLOGICAL REPORTS

IF3.8

2014-12-019

PREAI

New enantiomeric fluorine-containing derivatives of sulforaphane: Synthesis, absolute configurations and biological activity

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

IF5.9

2014-04-0121

PREAI

Identification of Novel Serotonin Transporter Compounds by Virtual Screening

JOURNAL OF CHEMICAL INFORMATION AND MODELING

IF5.3

2014-02-2634

OAAI

New validated HPLC methodology for the determination of (-)-trans-paroxetine and its enantiomer in pharmaceutical formulations with use of ovomucoid chiral stationary phase

ANALYTICAL AND BIOANALYTICAL CHEMISTRY

IF3.8

2014-01-108

OAAI

Synthesis, Antidepressant Evaluation and Docking Studies of Long-Chain Alkylnitroquipazines as Serotonin Transporter Inhibitors

CHEMICAL BIOLOGY & DRUG DESIGN

IF3.3

2013-04-117

OAAI

The new HPLC methodology for the chiral separation of tamsulosin enantiomers on amylose tris(3,5-dimethylphenylcarbamate) stationary phase

在直链淀粉三 (3，5-二甲基苯基氨基甲酸酯) 固定相上手性分离坦索罗辛对映体的新HPLC方法

IF6.1

2012-12-012

PRE

Synthesis, in vitro binding studies and docking of long-chain arylpiperazine nitroquipazine analogues, as potential serotonin transporter inhibitors

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

IF5.9

2012-03-013

OAAI

Molecular mechanism of serotonin transporter inhibition elucidated by a new flexible docking protocol

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

IF5.9

2012-01-0127

OAAI

Mass-spectrometric studies of new 6-nitroquipazines-serotonin transporter inhibitors

ANALYTICAL AND BIOANALYTICAL CHEMISTRY

IF3.8

2011-10-010

OAAI

Influence of new high affinity serotonin transporter ligands on cellular cAMP levels

PHARMACOLOGICAL REPORTS

IF3.8

2011-03-010

PREAI

Screening for new 5HT1A receptor agonists and antagonists

PHARMACOLOGICAL REPORTS

IF3.8

2010-09-011

PREAI